7/22/2013

Adynxx's AYX1 injection for chronic pain prevention has received fast-track designation from the FDA. The drug is in a midstage trial designed to evaluate its safety and efficacy in reducing or preventing postsurgical pain in patients undergoing unilateral total knee arthroplasty.

Related Summaries